Yang Liu

Yang Liu

Auto-generated profile, based on publicly available information

Yang Liu

Department of Orthopedic Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2022 in International Orthopaedics
Verified
Journal Article
Closed access
PDF file
DZDian Zhong
Dian Zhong
ZKZhen-Yong Ke
Zhen-Yong Ke
QCQiu Chen
Qiu Chen
YLYang Liu
Yang Liu
LLLu Lin
Lu Lin
YWYang Wang
Yang Wang

27 November 2019 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
XWXin Wang
Xin Wang
JSJunhao Sun
Junhao Sun
JTJianshi Tan
Jianshi Tan
PFPengzhong Fang
Pengzhong Fang
JCJinlei Chen
Jinlei Chen
YLYang Liu
Yang Liu
Background: The incidence of degenerative disc disease caused by intervertebral disc injury is increasing annually, seriously affecting the quality of life of patients and increasing the disease burden on society. The mechanisms of intervertebral disc degeneration include changes in extracellular matrix (ECM) deposition and tissue fibrosis. sIL-13Rα2-Fc potently inhibits interleukin (IL)-13, as well as blocks related cell signaling pathways and inhibits fibrosis in certain tissues. However, it is unknown whether sIL-13Rα2-Fc inhibits fibrosis in injured intervertebral discs and slows the process of degeneration. We hypothesized that sIL-13Rα2-Fc delays the progression of intervertebral disc degeneration by inhibiting intervertebral disc fibrosis and improving ECM deposition. Methods: A rat tail intervertebral disc degeneration model was established. Pathological changes in rat intervertebral disc tissue were observed by hematoxylin and eosin staining and Masson staining. Glycosaminoglycan (GAG), chondroitin sulfate (CS), keratan sulfate (KS), and hyaluronic acid (HA) contents were quantitatively analyzed by enzyme-linked immunosorbent assay. Type I and type II collagen expression levels were analyzed by reverse transcription-PCR and western blotting. Results: Hematoxylin and eosin staining and Masson staining revealed annulus fibrosus rupture, disordered arrangement, decreased nucleus pulposus tissue, and decreased collagen fiber in the rat intervertebral disc tissue. Following treatment with sIL-13Rα2-Fc, pathological changes in the rat intervertebral disc were reduced. Rat intervertebral disc tissue showed decreased GAG, CS-KS, and (HA) contents, increased type I collagen levels, and decreased type II collagen levels in degenerated intervertebral discs. sIL-13Rα2-Fc intervention increased the contents of GAG, CS, KS, and HA; inhibited the expression of type I collagen; and promoted the expression of type II collagen. Conclusion: These results demonstrate that intervertebral disc degeneration is associated with tissue fibrosis. sIL-13Rα2-Fc can regulate type I and type II collagen expression levels by increasing GAG, CS, KS, and HA contents, thereby slowing the progression of intervertebral disc degeneration.

1 December 2017 in World Neurosurgery
Verified
Journal Article
Closed access
QKQing-Jie Kong
Qing-Jie Kong
Helena Yuan WangHelena Yuan Wang
Helena Yuan Wang
YLYang Liu
Yang Liu
JSJingchuan Sun
Jingchuan Sun
XXXi-Ming Xu
Xi-Ming Xu
JSJian-Gang Shi
Jian-Gang Shi

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
XWXin Wang
Xin Wang
JTJianshi Tan
Jianshi Tan
JSJunhao Sun
Junhao Sun
PFPengzhong Fang
Pengzhong Fang
JCJinlei Chen
Jinlei Chen
YLYang Liu
Yang Liu
Background. Intervertebral disc degeneration is related to tissue fibrosis. ADAMTS can degrade the important components of the ECM during the process of intervertebral disc degeneration, ultimately resulting in the loss of intervertebral disc function. sIL‐13Rα2‐Fc can inhibit fibrosis and slow down the degeneration process, but the mechanism involved remains unclear. Objective. To determine the mechanism by which sIL‐13Rα2‐Fc inhibits ECM degradation and reduces intervertebral disc tissue fibrosis using a transcriptomics analysis. Methods. A rat model of caudal intervertebral disc degeneration was established, and Sirius red staining was used to observe the pathological changes in the caudal intervertebral disc. Transcriptome sequencing was employed to assess the gene expression profiles of the intervertebral disc tissues in the model group and the sIL‐13Rα2‐Fc‐treated group. Differentially expressed genes were identified and analyzed using GO annotation and KEGG pathway analyses. Real‐time fluorescence quantitative PCR was used to verify the expression levels of candidate genes. The levels of GAG and HA were quantitatively assessed by ELISA, and the levels of collagen I and collagen II were analyzed by western blotting. Results. Sirius red staining showed that in the model group, the annulus fibrosus was disordered, the number of breaks increased, and the type I collagen protein levels increased, whereas in the sIL‐13Rα2‐Fc group, the annulus fibrosus was ordered, the number of breaks decreased, and the type II collagen protein levels increased. In comparison with the model group, we identified 58 differentially expressed genes in the sIL‐13Rα2‐Fc group, and these were involved in 35 signaling pathways. Compared with those in the model group, the mRNA expression levels of Rnux1, Sod2, and Tnfaip6 in the IL‐13Rα2‐Fc group were upregulated, and the mRNA expression levels of Aldh3a1, Galnt3, Fgf1, Celsr1, and Adamts8 were downregulated; these results were verified by real‐time fluorescence quantitative PCR. TIMP‐1 (an ADAMTS inhibitor) and TIMP‐1 combined with the sIL‐13Rα2‐Fc intervention increased the levels of GAG and HA, inhibited the expression of type I collagen, and promoted the expression of type II collagen. Conclusion. Adamts8 may participate in the degradation of ECM components such as GAG and HA and lead to an imbalance in the ECM of the intervertebral disc, resulting in intervertebral disc degeneration. sIL‐13Rα2‐Fc promoted anabolism of the ECM and increased the levels of ECM components by inhibiting the expression of Adamts8, thus maintaining the dynamic equilibrium of the ECM and ultimately delaying intervertebral disc degeneration.